Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VESICARE LS
- Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / As
- Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis
- Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms
- Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
- Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP
- Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome
- Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
- Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
- Reproducibility Study of OABSS and Its Response to Treatment
- A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
- Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects
- Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
- Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects
- A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics
- A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder
- This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
- A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin
- A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)
- A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
- Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
- VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
- A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
- A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients
- Bacterial Genomic Sequencing in Overactive Bladder
- A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.
- Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms
- Incontinence & Intimate Partners: Assessing the Contribution of Treatment
- The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence
- Post Marketing Survey of Vesicare in Japan
- The Effect of Solifenacin on Post Void Dribbling in Women
- Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
- A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation
- Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
- A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy
- A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder
- A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment
- A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously
- Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)
- Anticholinergic vs. Botox Comparison Study
- Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
- Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse
- Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters
- Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
- Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers
- Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients
- Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency
- A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks
- Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder
- Solifenacin Succinate Versus Tolterodine 4mg Once Daily
- Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms
- Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
- Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
- Feasibility of "At-home" Titration of Solifenacin
- A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis
- Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
- Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy
- Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life
- Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
- Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms
- A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)
- Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder
- Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)
- A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
- A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
Clinical trials list
click for details